For: | Lin LC, Hsu TH, Huang KW, Tam KW. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials. World J Gastroenterol 2016; 22(23): 5445-5453 [PMID: PMC4910666 DOI: 10.3748/wjg.v22.i23.5445] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i23/5445.htm |
Number | Citing Articles |
1 |
Yan Sun, Jinping Zhang, Yuanyuan Chen. Efficacy and safety of Jianzhong decoction in treating peptic ulcers: a meta-analysis of 58 randomised controlled trials with 5192 patients. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-017-1723-2
|
2 |
Vasiliy Ivanovich Reshetnyak, Tatiana Magomedalievna Reshetnyak. Significance of dormant forms of <i>Helicobacter pylori</i> in ulcerogenesis. World Journal of Gastroenterology 2017; 23(27): 4867-4878 doi: 10.3748/wjg.v23.i27.4867
|
3 |
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano, Emad M El-Omar. Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report. Gut 2022; 71(9): 1724 doi: 10.1136/gutjnl-2022-327745
|
4 |
Giuseppe Losurdo, Floriana Giorgio, Andrea Iannone, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo, Enzo Ierardi. Role of concomitant therapy for <i>Helicobacter pylori</i> eradication: A technical note. World Journal of Gastroenterology 2016; 22(38): 8638-8640 doi: 10.3748/wjg.v22.i38.8638
|
5 |
Mei-Jyh Chen, Chien-Chuan Chen, Yen-Nien Chen, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu, Jyh-Ming Liou. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection. American Journal of Gastroenterology 2018; 113(10): 1444 doi: 10.1038/s41395-018-0217-2
|
6 |
Sanjeev Kumar Jha, Manish K. Mishra, Kuldeep Saharawat, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial. Indian Journal of Gastroenterology 2019; 38(4): 325 doi: 10.1007/s12664-019-00949-4
|
7 |
Yuwei Deng, Wenjia Su, Junwen Zhu, Hongfei Ji, Xiaoping Zhou, Jingshu Geng, Jiayu Zhu, Qingyuan Zhang. Helicobacter pyloriinfection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma. Journal for ImmunoTherapy of Cancer 2021; 9(10): e002947 doi: 10.1136/jitc-2021-002947
|
8 |
Ju Yup Lee, Kyung Sik Park. Optimal First-Line Treatment forHelicobacter pyloriInfection: Recent Strategies. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/9086581
|
9 |
André Mesquita, Carlos Rocha-Castro, Daniela Guimarães, Joana Costa, Joana Soutinho, Tiago Taveira-Gomes. Multicentric Study to Assess Helicobacter pylori Incidence, Patient Reported Adverse Events, Compliance and Effectiveness, in Real-World Setting. International Journal of Environmental Research and Public Health 2022; 19(19): 12847 doi: 10.3390/ijerph191912847
|
10 |
Anthony O'Connor, Dominique Lamarque, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2017. Helicobacter 2017; 22(S1) doi: 10.1111/hel.12410
|